Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML

Acute myeloid leukemia (AML) is a deadly heterogeneous hematologic malignancy. Despite the well-characterized genetic characteristics and new promising targeted therapies for AML, the clinical outcome remains suboptimal. Galectin-9 (Gal-9) is a good potential target due to its immunosuppressive capa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cancer
Autori principali: Zhang, Yongping, Xue, Song, Hao, Qi, Liu, Fuhong, Huang, Wenqiu, Wang, Jingbo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2021
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176406/
https://ncbi.nlm.nih.gov/pubmed/34093826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.53686
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi